Clinical trial
A Phase III, Randomized, Multicenter, Investigational, Open Label Clinical Trial That Will Examine Whether Treatment With Endovascular Thrombectomy is Superior to Standard Medical Therapy Alone in Patients Who Suffer a Distal Medium Vessel Occlusion Ischemic Strokes.
NCT05983757 is registered in ClinicalTrials.gov with Raul Nogueira as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase III, Randomized, Multicenter, Investigational, Open Label Clinical Trial That Will Examine Whether Treatment With Endovascular Thrombectomy is Superior to Standard Medical Therapy Alone in Patients Who Suffer a Distal Medium Vessel Occlusion Ischemic Strokes.
- Lead sponsor
- Raul Nogueira
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- April 2, 2024
- Completion date
- November 30, 2027
- Enrollment
- 584 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.